Kathy S Albain Selected Research

Kathy S Albain Research Topics

Disease

81	Breast Neoplasms (Breast Cancer) 12/2021 - 01/2003
42	Neoplasms (Cancer) 01/2022 - 01/2003
17	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 08/2002
7	Lung Neoplasms (Lung Cancer) 01/2021 - 10/2003
6	Peripheral Nervous System Diseases (PNS Diseases) 01/2019 - 07/2013
5	Neutropenia 11/2010 - 05/2003
4	Pathologic Complete Response 12/2021 - 01/2020
4	Fatigue 02/2016 - 12/2011
3	Noninfiltrating Intraductal Carcinoma (DCIS) 02/2016 - 08/2004
3	Disease Progression 12/2011 - 05/2005
3	Neoplasm Metastasis (Metastasis) 08/2009 - 11/2003
2	Triple Negative Breast Neoplasms 12/2021 - 07/2016
2	Residual Neoplasm 11/2021 - 07/2016
2	Infertility (Sterility) 08/2021 - 06/2015
2	Premature Menopause 08/2021 - 01/2019
2	Amenorrhea 08/2021 - 06/2015
2	Tics (Tic) 01/2020 - 10/2019
2	Chronic Disease (Chronic Diseases) 01/2017 - 07/2013
2	Margins of Excision 02/2016 - 02/2016
2	Heart Failure 01/2015 - 12/2009
2	Pneumonia (Pneumonitis) 09/2006 - 05/2003
1	Hyperglycemia 10/2021
1	Cognitive Dysfunction 10/2020

Drug/Important Bio-Agent (IBA)

28	Hormones (Hormone)IBA 12/2021 - 01/2005
17	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 05/2006
16	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 01/2005
12	Trastuzumab (Herceptin)FDA Link 11/2021 - 11/2011
12	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 01/2005
10	Tamoxifen FDA LinkGeneric 01/2020 - 01/2005
9	Estrogen ReceptorsIBA 01/2020 - 12/2004
9	taxaneIBA 01/2020 - 05/2003
8	ErbB Receptors (EGF Receptor)IBA 01/2020 - 10/2003
7	human ERBB2 proteinIBA 12/2021 - 05/2014
7	Gemcitabine FDA Link 07/2012 - 01/2003
7	Cisplatin (Platino)FDA LinkGeneric 07/2012 - 08/2002
6	Biomarkers (Surrogate Marker)IBA 10/2021 - 08/2004
5	AnthracyclinesIBA 01/2020 - 03/2008
5	PlatinumIBA 10/2019 - 01/2003
5	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 01/2005
5	Anastrozole (Arimidex)FDA LinkGeneric 01/2019 - 08/2012
5	Docetaxel (Taxotere)FDA Link 11/2011 - 05/2003
4	Ado-Trastuzumab EmtansineIBA 11/2021 - 01/2014
4	Pharmaceutical PreparationsIBA 10/2021 - 12/2006
4	Proteins (Proteins, Gene)FDA Link 01/2020 - 12/2006
3	pertuzumabIBA 11/2021 - 01/2014
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 01/2018
3	Fulvestrant (Faslodex)FDA Link 01/2019 - 08/2012
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2003
3	Carboplatin (JM8)FDA LinkGeneric 07/2016 - 01/2009
3	Tyrosine Kinase InhibitorsIBA 07/2015 - 10/2003
3	Etoposide (VP 16)FDA LinkGeneric 08/2009 - 08/2002
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 01/2021
2	veliparibIBA 01/2021 - 07/2016
2	AntioxidantsIBA 10/2020 - 11/2010
2	APTIBA 07/2019 - 06/2015
2	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 01/2005
2	Aromatase InhibitorsIBA 01/2019 - 11/2008
2	Goserelin (Zoladex)FDA Link 01/2019 - 01/2015
2	Phenobarbital (Luminal)FDA Link 01/2019 - 01/2015
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 01/2015
2	Estrogens (Estrogen)FDA Link 01/2018 - 01/2017
2	Taxoids (Taxanes)IBA 01/2018 - 12/2011
2	Lapatinib (GW572016)FDA Link 01/2016 - 07/2015
2	Drug CombinationsIBA 07/2015 - 01/2014
2	Vitamin D FDA LinkGeneric 04/2015 - 11/2008
2	EnzymesIBA 05/2014 - 11/2010
2	Vinorelbine (Navelbine)FDA LinkGeneric 11/2011 - 04/2006
2	Gefitinib (Iressa)FDA Link 05/2008 - 10/2003
1	durvalumabIBA 12/2021
1	olaparibIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	thymidine kinase 1IBA 11/2021
1	ganitumabIBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	ResveratrolIBA 01/2020
1	QuercetinIBA 01/2020
1	MK 2206IBA 01/2020
1	GenisteinIBA 01/2020
1	ApigeninIBA 01/2020
1	Phytoestrogens (Phytoestrogen)IBA 01/2020
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	naringeninIBA 01/2020
1	Cyclin D2IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Cyclin-Dependent Kinase 4IBA 10/2019

Therapy/Procedure

49	Therapeutics 01/2022 - 10/2003
48	Drug Therapy (Chemotherapy) 01/2022 - 01/2003
20	Adjuvant Chemotherapy 10/2020 - 12/2004
8	Neoadjuvant Therapy 12/2021 - 01/2010
7	Radiotherapy 01/2020 - 08/2002
5	Chemoradiotherapy 01/2021 - 08/2002
4	Segmental Mastectomy (Lumpectomy) 02/2016 - 01/2005
4	Combined Modality Therapy 12/2005 - 05/2003
3	Aftercare (After-Treatment) 01/2021 - 05/2005
2	Immunotherapy 01/2022 - 01/2021
2	Chemoprevention 01/2017 - 08/2004
2	Mastectomy (Mammectomy) 04/2015 - 01/2010
1	Investigational Therapies (Experimental Therapy) 11/2021